Quasispecies as predictive response factors for antiviral treatment in patients with chronic hepatitis C

被引:9
作者
Salmeron, Javier
De Rueda, Paloma Munoz
Ruiz-Extremera, Angela
Casado, Jorge
Huertas, Carlos
Bernal, Maria Del Carmen
Rodriguez, Luis
Palacios, Angel
机构
[1] Hosp Univ San Cecilio, Gastroenterol Unit, Granada 18012, Spain
[2] Hosp Univ San Cecilio, Paediat Serv, Granada 18012, Spain
[3] Hosp Univ San Cecilio, Dept Microbiol, Granada 18012, Spain
关键词
hepatitis C virus; predictive factors; quasispecies; HCV core antigen; interferon; ribavirin;
D O I
10.1007/s10620-006-9347-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The object of this study was to evaluate the viral factor, especially the quasispecies, as predictive of sustained virologic response. We studied the quasispecies, genotype, viral load, and hepatitis C (HCV) cAg in 41 patients with chronic hepatitis C treated with interferon and in 84 with interferon and ribavirin. In the interferon group, responders presented a lower viral load. From logistic regression analysis of patients treated with interferon plus ribavirin, independent predictors for sustained virologic response were genotype 3a, a low baseline viral load and <= 3 bands quasispecies. Genotype and viral load presented higher specificity and positive predictive value than did quasispecies. In patients with genotype 1, viral load <= 5 x 10(5) IU/mL and <= 3 quasispecies were predictive for sustained virologic response. In conclusion, the predictive factors of virologic response are genotype, viral load, and quasispecies. Quasispecies did not improve on the genotype or the viral load as predictors of virologic response.
引用
收藏
页码:960 / 967
页数:8
相关论文
共 42 条
[1]   Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome [J].
Alter, HJ ;
Seeff, LB .
SEMINARS IN LIVER DISEASE, 2000, 20 (01) :17-35
[2]   Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy [J].
Berg, T ;
Sarrazin, C ;
Herrmann, E ;
Hinrichsen, H ;
Gerlach, T ;
Zachoval, R ;
Wiedenmann, B ;
Hopf, U ;
Zeuzem, S .
HEPATOLOGY, 2003, 37 (03) :600-609
[3]   Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection [J].
Chambers, TJ ;
Fan, XF ;
Droll, DA ;
Hembrador, E ;
Slater, T ;
Nickells, MW ;
Dustin, LB ;
DiBisceglie, AM .
JOURNAL OF VIROLOGY, 2005, 79 (05) :3071-3083
[4]   The scientific challenge of hepatitis C [J].
Cohen, J .
SCIENCE, 1999, 285 (5424) :26-30
[5]  
Davidson M, 1927, LANCET, V1, P122
[6]   RIBAVIRIN AS THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DIBISCEGLIE, AM ;
CONJEEVARAM, HS ;
FRIED, MW ;
SALLIE, R ;
PARK, Y ;
YURDAYDIN, C ;
SWAIN, M ;
KLEINER, DE ;
MAHANEY, K ;
HOOFNAGLE, JH ;
WRIGHT, D .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (12) :897-&
[7]  
DOMINGO E, 1996, VIRAL HEPATITIS REV, V2, P247
[8]   Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus [J].
Doughty, AL ;
Painter, DM ;
McCaughan, GW .
JOURNAL OF HEPATOLOGY, 2000, 32 (01) :126-134
[9]  
EIGEN M, 1988, RNA GENETICS, P211
[10]   FLUCTUATION OF HEPATITIS-C VIRUS QUASI-SPECIES IN PERSISTENT INFECTION AND INTERFERON TREATMENT REVEALED BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS [J].
ENOMOTO, N ;
KUROSAKI, M ;
TANAKA, Y ;
MARUMO, F ;
SATO, C .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :1361-1369